CADRENAL THERAPEUTICS INC
CVKD·127636207·US·Common Stock·Healthcare - Biotechnology
CVKD (CADRENAL THERAPEUTICS INC) is held by 12 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($231,429), GEODE CAPITAL MANAGEMENT, LLC ($110,724), VANGUARD FIDUCIARY TRUST CO ($42,552). Net institutional sentiment: Mixed.
12
Holders
Avg rating(5 Elite)
$448,186
Total Value
45% (14)
Fund Consensus
5 buying - 6 selling
Who's Trading
InsiderPXPham Quang XSell $15KMay 28, 2026
InsiderPXPham Quang XSell $17KMay 12, 2026
InsiderPXPham Quang XSell $37KMay 11, 2026
InsiderSKSzot Matthew KSell $69KDec 29, 2025
InsiderPXPham Quang XSell $18KOct 27, 2025
InsiderSKSzot Matthew KSell $25KOct 27, 2025
InsiderPXPham Quang XSell $16KOct 24, 2025
InsiderSKSzot Matthew KSell $25KOct 24, 2025
InsiderPXPham Quang XSell $25KOct 13, 2025
InsiderSKSzot Matthew KSell $25KOct 13, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer